BioSpace News Archive

Sight Sciences, Inc., an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, announces several Company updates.

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced the grant of inducement awards to two new employees.

Nyxoah SA, a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, announced that it has appointed Mr.

BeyondSpring Inc., a clinical stage global biopharmaceutical company focused on developing innovative cancer therapies, announced that on December 29, 2022, the Company received a written notification from Nasdaq that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550.

Agilent Technologies Inc. announced that its board of directors has approved a new share repurchase program.

Kytopen announced it is assembling a group of experts in the diverse fields of immunology, synthetic biology, engineering, and manufacturing for its newly formed Scientific Advisory Board.

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today provided a preview of the company’s plans, estimated revenue and net product sales for Q4 and full year 2022 ahead of its presentation at the 41st Annual J.P. Morgan Healthcare Conference.

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that CEO Dr. Hans Keirstead has joined the board of the esteemed Human Immunome Project.

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”) today announced the Company’s Phase 2 clinical trial of ATH434 for the treatment of patients with Multiple System Atrophy (MSA) is now open for enrollment at Vanderbilt University Medical Center in Nashville, Tennessee.

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic” or the “Company”), a medical device company commercializing IzoView, a dedicated breast CT (computed tomography) imaging platform, for the more accurate detection and diagnosis of breast cancers, is pleased to release the first video showcasing the completed engineering of IzoView.